Media Coverage

Sigrid Therapeutics Secures U.S. Market Access for SiPore® Technology

Nov 16, 2026

Media: Yahoo Finance

Yahoo Finance carries the news that Sigrid has secured US market access for SiPore® following the SHINE prediabetes study.

US market accessSHINE trial
Sigrid Therapeutics Secures U.S. Market Access for SiPore® Technology
Read the full article

Syndicated on Yahoo Finance, this story covers Sigrid securing US market access for its patented SiPore® technology after the SHINE study, the largest study of its kind in prediabetes.

← Back to all insights